⫪ Medical

Beijing Qinghan Medical Technology Co., Ltd. was established in early 2022. The company relies on the transformation of research results from the Precision Medicine Research Institute of Tsinghua University, which were completed by a cross-disciplinary medical-engineering research group jointly led by Academician Dong Jiahong of the Chinese Academy of Engineering and Academician Luo Jianbin of the Chinese Academy of Sciences. Qinghan Medical actively undertakes national major scientific research projects, focusing on the development of core technologies such as blood microcirculation, extracorporeal blood oxygenation, and organ mechanical perfusion. It aims to break foreign technological monopolies, independently research and develop a full range of high-end medical equipment, and achieve industrialization. The company's current product pipeline under registration mainly includes heart-lung machines and membrane oxygenators (ECMO), pulmonary dialysis medical devices, etc.